Drug Profile
Research programme: Chaga's disease therapeutics - Epichem/DNDi
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Drugs for Neglected Diseases Initiative Foundation; Epichem
- Class Heterocyclic compounds
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Chagas disease
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Chagas'-disease in Australia (PO)
- 02 Dec 2010 Preclinical trials in Chagas' disease in Australia (PO)